Skip to content

Clinical trials

Neurodegenerative Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20161
20191
20201
20221
20231
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Not yet recruiting2
Recruiting2
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital2
Eli Lilly and Company2
Taipei Medical University Shuang Ho Hospital2
TauRx Therapeutics Ltd2
AbbVie1
AstraZeneca1
China Medical University Hospital1
Elixiron Immunotherapeutics Inc.1
Intellia Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases13
Alzheimer Disease7
Dementia7
Brain Diseases6
Nervous System Diseases5
Cognitive Dysfunction4
Central Nervous System Diseases3
Parkinson Disease3
Mental Disorders2
Neurocognitive Disorders2

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.